Obesity, Medicaid and Biden Administration

Biden Administration Proposes Covering Obesity Drugs In Medicare And Medicaid
It's uncertain whether the Biden administration proposal to cover obesity drugs in Medicare and Medicaid will survive decisions made by the incoming Trump administration.
Should Medicare, Medicaid Cover Anti-Obesity Drugs? Doctors Speak Out
Joe Biden wants diabetes drugs that aid weight loss and treat obesity, such as Wegovy, to fall under Medicare and Medicaid.
Biden Says Medicare, Medicaid Should Cover Obesity Drugs—What Could That Mean for Access?
The Biden Administration released plans for a new rule that would require Medicare and Medicaid to cover anti-obesity medications. But it's not clear if the proposed change will go into effect.
7.4 million Americans could gain Medicare or Medicaid coverage for anti-obesity drugs under Biden proposal
Millions more senior citizens and lower-income Americans could obtain coverage for costly anti-obesity drugs under a proposal being unveiled Tuesday by the Biden administration.
Ozempic, Wegovy covered by Medicare and Medicaid under Biden admin proposal for anti-obesity GLP-1 drugs
The Biden administration is looking to expand access to anti-obesity GLP-1 drugs like Ozempic and Wegovy for people who have Medicare and Medicaid.
Obesity Drugs Would Be Covered by Medicare and Medicaid Under Biden Proposal
The Biden administration, in one of its last major policy directives, proposed on Tuesday that Medicare and Medicaid cover obesity medications, a costly and probably popular move that the Trump administration would need to endorse to become official.
Biden proposes expanding obesity drug coverage under Medicare and Medicaid
The Biden administration has proposed a new rule to “significantly” expand coverage of anti-obesity medications for Americans with Medicare and Medicaid.
New Proposal Aims to Expand Medicaid and Medicare Coverage for Obesity Drugs
If made official, the proposed rule would give Part D and Medicaid beneficiaries expanded coverage to antiobesity drugs starting in 2026.
Biden Proposes Coverage of Obesity Drugs in Medicare, Medicaid
Medicare and Medicaid recipients with obesity would have access to coverage of pricey GLP-1 receptor agonists like semaglutide (Wegovy) or tirzepatide (Zepbound) under a regulation proposed Tuesday by the Centers for Medicare & Medicaid Services (CMS).
Biden’s plan for Medicare coverage of weight-loss drugs would drive up costs by billions of dollars
Biden to require Medicare and Medicaid to cover weight loss drugs
President Biden plans to roll out a new plan that would require coverage of weight loss drugs for patients of Medicare and Medicaid. The move could potentially help some seven million Americans pay for the expensive drugs,
Biden proposes expanded Medicare, Medicaid coverage of obesity drugs
U.S. President Joe Biden on Tuesday proposed expanding coverage of anti-obesity drugs, like Novo Nordisk's Wegovy, for more ...
phillyvoice.com8d
Obesity drugs would be covered by Medicare and Medicaid under Biden administration proposal
An estimated 7.4 million people would gain access to weight-loss drugs like Ozempic and Zepbound, which have out-of-pocket ...
Yahoo8d
Biden proposes Medicare, Medicaid coverage of obesity drugs
The Biden administration proposed a new rule Tuesday that would allow anti-obesity drugs like Wegovy and Zepbound to be ...